Page 140 - ESHRE2019
P. 140
New York attorney general sues stem cell clinic
8 April 2019 Appeared in BioNews 994
The clinic uses stem cells derived from the patients' own fat tissues to treat a range of medical conditions including autoimmune disease, erectile dysfunction, cardiac and pulmonary disease, and orthopaedic and neurological diseases. According to the lawsuit, PASC made misleading claims on its website as well as on social media platforms about the effectiveness of the treatments.
The starting price for procedures offered at the clinic is US$3995.
The clinic also made claims that its procedures are supported by existing literature and provided links to articles and scientific studies on its website, but these references do not provide sufficient evidence to support PASC's claims that its procedures can be used to treat the conditions described. The lawsuit also alleges that PASC falsely represents that its procedures are approved by the Food and Drug Administration (FDA) and that patients receiving stem cell treatment at the clinic were also made to believe that they were part of a patient-funded research study.
PCC Stem Cells - ESHRE Vienna 2019
anna.veiga@dexeus.com aveiga@cmrb.eu
PCC Stem Cells - ESHRE Vienna 2019
138
135
